NFE2L2 and esophageal squamous cell carcinoma: High nuclear NFE2L2 expression predicted shorter overall survival in patients with the dual expression of NFE2L2 and NQO1; furthermore, the presence of both nuclear NFE2L2 expression and the presence of NFE2L2 alterations were shown to accurately predict the prognosis of ESCC patients [85].